EUA
Synapse Biomedical, Inc. TransAeris Diaphragmatic Pacing Therapy System (DPTS)
FDA Emergency Use Authorization · Apr 13, 2020
Key facts
| Product | Synapse Biomedical, Inc. TransAeris Diaphragmatic Pacing Therapy System (DPTS) |
|---|---|
| Product type | Diaphragmatic Pacing Therapy System (DPTS) |
| Product code | QPR |
| Date | Apr 13, 2020 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: